Kohmann Bosshard Financial Services’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$615K Sell
2,446
-86
-3% -$18.5K 0.05% 123
2026
Q1
$551K Sell
2,532
-13
-0.5% -$2.88K 0.05% 117
2025
Q4
$581K Sell
2,545
-34
-1% -$7.75K 0.05% 140
2025
Q3
$597K Sell
2,579
-82
-3% -$16.7K 0.06% 120
2025
Q2
$494K Buy
2,661
+2
+0.1% +$372 0.06% 116
2025
Q1
$557K Buy
2,659
+150
+6% +$29.2K 0.07% 114
2024
Q4
$446K Buy
2,509
+122
+5% +$22.4K 0.05% 118
2024
Q3
$471K Buy
2,387
+2
+0.1% +$373 0.06% 118
2024
Q2
$409K Buy
2,385
+2
+0.1% +$331 0.06% 124
2024
Q1
$434K Buy
2,383
+274
+13% +$47.2K 0.06% 120
2023
Q4
$327K Buy
2,109
+215
+11% +$31.3K 0.05% 140
2023
Q3
$282K Hold
1,894
0.05% 140
2023
Q2
$255K Buy
+1,894
New +$278K 0.04% 152

Other funds holding ABBV

Kohmann Bosshard Financial Services's ABBV Position: Q2 2026 in Review

Kohmann Bosshard Financial Services reduced its AbbVie (ABBV) stake by 3.4% in Q2 2026, selling an estimated $18.5K and leaving 2,446 shares worth $615K. The position accounts for 0.05% of the portfolio, ranked #123.

Kohmann Bosshard Financial Services first reported a position in ABBV in Q2 2023 and has held it in 13 quarters since. 1,589 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Kohmann Bosshard Financial Services held 2,446 shares of AbbVie worth $615K as of Q2 2026.
  • Kohmann Bosshard Financial Services sold 86 AbbVie shares in Q2 2026, an estimated $18.5K.
  • AbbVie made up 0.05% of Kohmann Bosshard Financial Services's portfolio in Q2 2026, its #123 holding.
  • Kohmann Bosshard Financial Services first reported a position in AbbVie in Q2 2023 and has held it in 13 quarters since.
  • 1,589 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Kohmann Bosshard Financial Services's 13F filing for Q2 2026, filed 15 Jul 2026.